Definitive Contract 75F40119C10104
Award Date
9/9/19
Potential Completion Date
3/29/24
Potential Value
$670K
Federal Agency
Food and Drug Administration
Ultimate Awardee
University System Of Maryland
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
This federal contract award, valued at $302,375.01, was issued by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) to conduct "Genome Sequencing of Mosquito Borne Viral Pathogens in Support of FDA ARGOS." The award is a definitive, firm fixed-price contract with no set-aside designation. UMB, the prime contractor, is a major public research university that frequently collaborates with federal agencies on biomedical research, healthcare services, and...
This is a $164,509.80 firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to the University of Maryland, Baltimore (UMB) for MS research services. The contract has a performance period through November 30, 2024. UMB is conducting the research as the prime contractor, with no set-aside designation noted. The University System of Maryland (USM) is the parent organization providing institutional support to UMB. UMB has a track record of...
This is a firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) on March 31, 2020. The contract is valued at $781,292.00 and has a completion date of June 30, 2024. The contract was not set aside for any socioeconomic program. UMB, a state government-owned educational institution, is providing research and other services to the CDC through this contract. The University System of Maryland is the parent...
This is a $879,424.00 firm fixed-price service agreement contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to the University of Maryland, Baltimore (UMB) on February 28, 2017. The contract has a base year period of performance ending on February 28, 2020, with no set-aside designation. UMB is providing services under this contract, which is part of a larger $6 million Blanket Purchase Agreement with the Department of Veterans Affairs for reagents, supplies,...
This is a $460,000 firm-fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) to conduct research on characterizing albumin-bound nanoparticle drugs using nuclear magnetic resonance (NMR) spectroscopy. The contract, which does not have a set-aside designation, has a period of performance ending on September 29, 2026. UMB, a major public research university, often serves as a prime contractor on federal contracts and...
This is a federal contract award from the Department of Defense's Bureau of Medicine and Surgery (BUMED) to the University of Maryland, Baltimore (UMB), a major public research university. The contract is for $125,877.60 in tuition and fees, with a fixed-price delivery order, and does not have a set-aside designation. UMB is serving as the prime contractor on this award, which is associated with a larger $6 million Blanket Purchase Agreement the university holds with the Department of Veterans...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration to the University of Maryland, Baltimore (UMB) for a scientific study. The $1,144,121.35 firm fixed price contract has a potential completion date of September 30, 2020. UMB is conducting the research under a delivery order contract and there is no set-aside designation. As a subcomponent of the University System of Maryland, UMB has a history of providing research, healthcare, and...
This is a $340,198.05 firm fixed-price delivery order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to the University of Maryland, Baltimore (UMB) on June 3, 2024. The contract provides tuition and fees for an unspecified period ending on December 31, 2024. UMB, a major public research university, frequently receives federal contracts and grants to support its research, education, and clinical activities across fields such as medicine, nursing, pharmacy,...
This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to the University of Maryland, Baltimore (UMB) as the prime contractor. The $78,016.75 firm fixed-price delivery order is for tuition and fees, with no set-aside designation. UMB is a major public research university that frequently receives federal contracts and grants to support its research, education, and clinical activities across diverse fields like medicine, nursing, pharmacy, and law. This...